Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › superficial basal cell carcinoma

Superficial basal cell carcinoma

Part of Cancer

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for superficial basal cell carcinoma

4 trials tracked for superficial basal cell carcinoma: 2 in phase 3 or 4.

4Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2 Phase 2 1 Other / NA 1
  1. Phase 3 Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma Completed
  2. Phase 3 Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream Completed
  3. Phase 2 Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma Completed
  4. N/A Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis reports high pooled complete response with ALA/MAL photodynamic therapy for superficial BCC
Oncology Meta-analysis
Meta-analysis reports high pooled complete response with ALA/MAL photodynamic therapy for superficial BCC Light vs. Scalpel: New Skin Cancer Data
This PRISMA 2020 systematic review and meta-analysis of 55 studies (2123 patients, 2995 lesions) evaluated ALA-PDT and MAL-PDT for superfici…
Light therapy with cream may match surgery for treating common skin cancer while avoiding scars and functional damage to your face or neck.
Frontiers Apr 17, 2026

Research across Cancer

Related studies from across the Cancer family.

Systematic review and meta-analysis of vismodegib for periocular and orbital basal cell carcinoma
Rheumatology Meta-analysis
Systematic review and meta-analysis of vismodegib for periocular and orbital basal cell carcinoma Vismodegib shows response rates for periocular and orbital basal cell carcinoma
This systematic review and meta-analysis of 764 patients with periocular or orbital basal cell carcinoma found that vismodegib achieved comp…
A review of 764 patients found vismodegib helped shrink tumors, but side effects were common and led many to stop treatment.
Frontiers May 11, 2026